Delivery Order SPE2DB22D3501-SPE2DB24FWC18
Award Date
6/26/24
Potential Completion Date
6/27/24
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4564793392 Ondansetron ODT 4 mg tablets. The contract, valued at $1,388.49, was awarded on June 3, 2024 by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 4, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not associated with a set-aside designation. Amerisourcebergen is a major supplier of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4565133985 - ondansetron ODT 8 mg tablets in 30s packages. The $1,337.25 contract is a firm fixed price delivery order placed by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract has an ultimate completion date of July 15, 2024 and was awarded on July 12, 2024 without any set-aside designation. Amerisourcebergen, a major...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order valued at $46,836.72 from the Defense Logistics Agency (DLA) for the supply of 4,560,650 units of the drug Ondansetron ODT 4 mg tablet. The contract has a period of performance through April 20, 2023, and utilizes a firm fixed price pricing structure. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is a delivery order for 4,565,504,016 units of the pharmaceutical product Ondansetron ODT 4 mg tablets. The award, valued at $36,904.83, was made by the Defense Logistics Agency (DLA) and does not have a set-aside designation. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, supporting various defense and civilian agencies through its extensive...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division by the Defense Logistics Agency (DLA) is for the delivery of Ondansetron ODT 8 mg tablets in 30-count packages. The $5,334.66 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a wide range of medical commodities from Amerisourcebergen to support military treatment programs and...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office division. The $19,006.49 contract is for the provision of 4,565,032,100 units of the pharmaceutical product Ondansetron ODT 4 mg tablets. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides the Defense Logistics Agency (DLA) with a range of pharmaceutical products and medical supplies for military treatment programs and facilities worldwide. The $10,302.24 Firm Fixed Price Delivery Order contract covers the supply of Ondansetron HCL 4 mg tablets, with a completion date of July 15, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,937.73 firm fixed-price delivery order is for the supply of 4,567,909,903 units of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of April 15, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation, is for the delivery of 4,565,047,457 units of the prescription medication Ondansetron ODT 4 mg tablets. The $1,251.66 firm fixed-price contract was awarded on July 1, 2024 by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 2, 2024. This appears to be a delivery order under...
The U.S. Defense Logistics Agency (DLA) awarded a $14,550.99 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division. The order is for the supply of 4,564,299,405 units of the pharmaceutical product Ondansetron ODT 8 mg Tablets. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. The IDC enables DLA to efficiently procure essential...